首页> 外文期刊>The pharmaceutical journal >Practice-based commissioning warning
【24h】

Practice-based commissioning warning

机译:基于实践的调试警告

获取原文
获取原文并翻译 | 示例
           

摘要

Community pharmacists'profits could be negatively affected if they fail to get involved with practice-based commissioning,according to guidance launched this week by the Royal Pharmaceutical Society.The guidance,developed with support from the National Pharmacy Association,the Pharmaceutical Services Negotiating Committee,the Company Chemists'Association and NHS Primary Care Contracting,outlines the benefits for community pharmacists-who become involved in PBC as well as the risks of not doing so.
机译:根据皇家药学会本周发布的指南,如果社区药师的利益未能参与基于实践的调试,则可能会受到负面影响。该指南是在国家药房协会,药学服务谈判委员会,公司化学家协会和NHS初级保健承包,概述了社区药剂师的利益-他们参与了PBC以及不这样做的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号